Electrochemical lateral flow assays: A new frontier for rapid and quantitative biosensing

Electrochemical lateral flow assays (eLFAs) have emerged as a promising alternative to traditional colorimetric LFAs, particularly for applications requiring quantitative readouts and improved sensitivity. Over the past two years, significant advancements have been made in eLFA design, fabrication, and analytical performance, positioning them as promising candidates for decentralized diagnostics and point-of-care (POC) testing. This review highlights recent advances in electrode integration techniques, redox-based signal amplification strategies, and the incorporation of wireless and battery-free electrochemical readout platforms. Multiplexed detection and real-time wireless data transmission have also been demonstrated, further increasing the utility of eLFAs in clinical and field settings. Additionally, innovative strategies to control contact pressure, optimize sample flow, and maintain device stability are being explored to improve reproducibility and usability. Despite these advancements, challenges remain, including biofouling, variability in sample matrices, and the need for standardized protocols across platforms.